Phenotypic and Transcriptomic Lymphocytes Changes in Allograft Recipients After Intravenous Immunoglobulin Therapy in Kidney Transplant Recipients.


Journal

Frontiers in immunology
ISSN: 1664-3224
Titre abrégé: Front Immunol
Pays: Switzerland
ID NLM: 101560960

Informations de publication

Date de publication:
2020
Historique:
received: 22 09 2019
accepted: 08 01 2020
entrez: 11 2 2020
pubmed: 11 2 2020
medline: 24 2 2021
Statut: epublish

Résumé

High dose intravenous immunoglobulin (IVIG) are widely used after kidney transplantation and its biological effect on T and B cell phenotype in the context of maintenance immunosuppression was not documented yet. We designed a monocentric prospective cohort study of kidney allograft recipients with anti-HLA donor specific antibodies (DSA) without acute rejection on screening biopsies treated with prophylactic high-dose IVIG (2 g/kg) monthly for 2 months. Any previous treatment with Rituximab was an exclusion criterion. We performed an extensive analysis of phenotypic and transcriptomic T and B lymphocytes changes and serum cytokines after treatment (day 60). Twelve kidney transplant recipients who completed at least two courses of high-dose IVIG (2 g/kg) were included in a median time of 45 (12-132) months after transplant. Anti-HLA DSA characteristics were similar before and after treatment. At D60, PBMC population distribution was similar to the day before the first infusion. CD8

Identifiants

pubmed: 32038663
doi: 10.3389/fimmu.2020.00034
pmc: PMC6993066
doi:

Substances chimiques

HLA Antigens 0
Immunoglobulin G 0
Immunoglobulins, Intravenous 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

34

Informations de copyright

Copyright © 2020 Pilon, Bigot, Grondin, Thiolat, Lang, Cohen, Grimbert and Matignon.

Références

Immunotherapy. 2015;7(4):377-98
pubmed: 25917629
N Engl J Med. 2012 Nov 22;367(21):2015-25
pubmed: 23171098
Clin Chem. 2007 Apr;53(4):766-72
pubmed: 17332152
Am J Transplant. 2003 Jun;3(6):653-64
pubmed: 12780556
N Engl J Med. 2008 Jul 17;359(3):242-51
pubmed: 18635429
Kidney Int. 2010 Sep;78(5):503-13
pubmed: 20531452
Am J Transplant. 2015 Oct;15(10):2718-25
pubmed: 25989263
Int Immunol. 2017 Dec 30;29(11):491-498
pubmed: 28666326
Transplantation. 2015 Oct;99(10):2029-37
pubmed: 26102615
J Neuroimmunol. 2014 Sep 15;274(1-2):225-9
pubmed: 25002077
Transplantation. 2014 Aug 15;98(3):312-9
pubmed: 24770617
Eur Cytokine Netw. 2018 Jun 1;29(2):48-51
pubmed: 30078783
N Engl J Med. 2011 Jul 28;365(4):318-26
pubmed: 21793744
Transplantation. 2010 Jun 15;89(11):1403-10
pubmed: 20386362
Clin J Am Soc Nephrol. 2008 Sep;3(5):1461-8
pubmed: 18525007
J Immunol. 2006 Jan 15;176(2):770-7
pubmed: 16393960
Curr Opin Organ Transplant. 2014 Dec;19(6):591-7
pubmed: 25304815
Am J Transplant. 2014 May;14(5):1173-82
pubmed: 24730563
PLoS One. 2016 Apr 14;11(4):e0153355
pubmed: 27078882
J Am Soc Nephrol. 2004 Dec;15(12):3256-62
pubmed: 15579530
J Immunol. 2001 Oct 1;167(7):3610-8
pubmed: 11564773
Am J Transplant. 2007 May;7(5):1185-92
pubmed: 17359509
Am J Transplant. 2017 Jan;17(1):28-41
pubmed: 27862883
J Am Soc Nephrol. 2017 Jun;28(6):1912-1923
pubmed: 28255002
Curr Opin Organ Transplant. 2009 Aug;14(4):326-31
pubmed: 19448538
J Autoimmun. 2011 Feb;36(1):9-15
pubmed: 20970960
Hum Immunol. 2018 Sep;79(9):659-667
pubmed: 29913200
Am J Pathol. 1998 Oct;153(4):1257-66
pubmed: 9777957
PLoS One. 2017 Jun 27;12(6):e0178572
pubmed: 28654684
Transplantation. 2014 May 15;97(9):917-24
pubmed: 24827764
J Immunol. 2013 Sep 1;191(5):2818-28
pubmed: 23913968
Lancet. 2018 Jun 30;391(10140):2619-2630
pubmed: 29910042
Immunity. 2009 Jun 19;30(6):899-911
pubmed: 19464196
Cell. 2006 Sep 22;126(6):1121-33
pubmed: 16990136
J Am Soc Nephrol. 2010 Aug;21(8):1398-406
pubmed: 20634297
Transpl Int. 2016 Nov;29(11):1205-1215
pubmed: 27529401

Auteurs

Caroline Pilon (C)

APHP (Assistance Publique-Hôpitaux de Paris), Hôpital H. Mondor-A. Chenevier, Centre d'Investigation Clinique Biothérapie, Créteil, France.
Université Paris-Est, UMR_S955, UPEC, Créteil, France.
Inserm, U955, Equipe 21, Créteil, France.

Jeremy Bigot (J)

Université Paris-Est, UMR_S955, UPEC, Créteil, France.
Inserm, U955, Equipe 21, Créteil, France.

Cynthia Grondin (C)

APHP (Assistance Publique-Hôpitaux de Paris), Hôpital H. Mondor-A. Chenevier, Centre d'Investigation Clinique Biothérapie, Créteil, France.

Allan Thiolat (A)

Université Paris-Est, UMR_S955, UPEC, Créteil, France.
Inserm, U955, Equipe 21, Créteil, France.

Philippe Lang (P)

Université Paris-Est, UMR_S955, UPEC, Créteil, France.
Inserm, U955, Equipe 21, Créteil, France.
APHP (Assistance Publique-Hôpitaux de Paris), Hôpital H. Mondor-A. Chenevier, Nephrology and Transplantation Department, Créteil, France.

José L Cohen (JL)

APHP (Assistance Publique-Hôpitaux de Paris), Hôpital H. Mondor-A. Chenevier, Centre d'Investigation Clinique Biothérapie, Créteil, France.
Université Paris-Est, UMR_S955, UPEC, Créteil, France.
Inserm, U955, Equipe 21, Créteil, France.

Philippe Grimbert (P)

APHP (Assistance Publique-Hôpitaux de Paris), Hôpital H. Mondor-A. Chenevier, Centre d'Investigation Clinique Biothérapie, Créteil, France.
Université Paris-Est, UMR_S955, UPEC, Créteil, France.
Inserm, U955, Equipe 21, Créteil, France.
APHP (Assistance Publique-Hôpitaux de Paris), Hôpital H. Mondor-A. Chenevier, Nephrology and Transplantation Department, Créteil, France.

Marie Matignon (M)

APHP (Assistance Publique-Hôpitaux de Paris), Hôpital H. Mondor-A. Chenevier, Centre d'Investigation Clinique Biothérapie, Créteil, France.
Université Paris-Est, UMR_S955, UPEC, Créteil, France.
Inserm, U955, Equipe 21, Créteil, France.
APHP (Assistance Publique-Hôpitaux de Paris), Hôpital H. Mondor-A. Chenevier, Nephrology and Transplantation Department, Créteil, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH